NCT00528021

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 230 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 2 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The main purpose of this study is to investigate the safety and efficacy of an investigational treatment for head lice infestation against a placebo.

Detailed description

The main purpose of this study is to investigate the safety and efficacy of an investigational treatment for head lice infestation against a placebo.

Conditions

• Pediculus Humanus Capitis
• Head Lice

Interventions

Type	Name	Description
DRUG	Placebo	Vehicle Only
DRUG	BGC20-0582	BGC20-0582 is a topical gel formulation of a naturally derived product. Subjects are treated either once (day 1) or twice (day 1 and 7) with either placebo or BGC20-0582 at one of the three concentrations. Following application of the BGC20-0582 lice treatment gel of placebo the product is rinsed from the subjects hair.

Timeline

• Start date: 2007-08-01
• Primary completion: 2008-05-01
• Completion: 2008-06-01
• First posted: 2007-09-11
• Last updated: 2022-06-28
• Results posted: 2010-12-28

Locations

1 site across 1 country: United States